Will BeiGene Stock Rebound After A 15% Fall Over The Last Month?
- Tuesday, January 18, 2022, 7:21
- Market
- Add a comment
The stock price of BeiGene (NASDAQ: BGNE), a China-based biotechnology company focused on developing molecularly targeted and immuno-oncology drug candidates, has seen a fall of 15% over the last twenty-one trading days, while it is up 5% over the last week…
About the Author
admin123 has written 23544 stories on this site.
